stockportfolio.pro
Catalyst Pharmaceuticals, Inc. Net Income 2002–2025
Catalyst Pharmaceuticals, Inc. (CPRX) annual net income by fiscal year, computed from SEC filings.
| Fiscal year | Net Income | Net margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $214.33M | 36.4% | +30.8% |
| FY 2024 | $163.89M | 33.3% | +129.5% |
| FY 2023 | $71.41M | 17.9% | -14.0% |
| FY 2022 | $83.08M | 38.8% | +110.4% |
| FY 2021 | $39.48M | 28.0% | -47.3% |
| FY 2020 | $74.98M | 63.0% | +135.2% |
| FY 2019 | $31.88M | 31.2% | +193.7% |
| FY 2018 | $-34.00M | -6800.7% | -84.7% |
| FY 2017 | $-18.41M | — | -1.9% |
| FY 2016 | $-18.07M | — | +10.7% |
| FY 2015 | $-20.23M | — | -30.5% |
| FY 2014 | $-15.51M | — | -27.6% |
| FY 2013 | $-12.15M | — | -198.2% |
| FY 2012 | $-4.08M | — | +36.2% |
| FY 2011 | $-6.39M | — | -59.5% |
| FY 2010 | $-4.01M | — | +44.7% |
| FY 2009 | $-7.24M | — | +31.5% |
| FY 2008 | $-10.56M | — | -155.2% |
| FY 2007 | $-4.14M | — | -51.7% |
| FY 2006 | $-2.73M | — | -51.2% |
| FY 2005 | $-1.81M | — | -234.4% |
| FY 2004 | $-539,820 | — | -25.9% |
| FY 2003 | $-428,615 | — | -67.5% |
| FY 2002 | $-255,945 | — | — |
Source: Catalyst Pharmaceuticals, Inc. SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for Catalyst Pharmaceuticals, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeCatalyst Pharmaceuticals, Inc. — frequently asked questions
What is Catalyst Pharmaceuticals, Inc.'s net income?
Catalyst Pharmaceuticals, Inc. (CPRX) reported net income of $214.33M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Catalyst Pharmaceuticals, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.